Skip to Content
주식/증권 ➡️ 중립

BIAF Stock Slips Post Q1 Earnings Despite Strength in CyPath Lung

Yahoo Finance 05/14/2026 02:27:00 PM 17회
요약

bioAffinity posts softer first-quarter 2026 results after exiting lower-margin pathology services, though CyPath Lung adoption and clinical-trial progress gain traction.

원문 기사 보기
관련 뉴스
When will OpenAI go public? Traders bet on Spring of 2027
06/26/2026
Infleqtion's neutral atom quantum approach prompts Outperform initiation from Wedbush
06/26/2026
Belden initiated with Buy rating at Citi
06/26/2026
2 Healthcare Stocks for Long-Term Investors and 1 We Brush Off
06/26/2026
뉴스 목록으로